India
· Delayed Price · Currency is INR Windlas Biotech Statistics
Total Valuation
Windlas Biotech has a market cap or net worth of INR 19.98 billion. The enterprise value is 18.04 billion.
| Market Cap | 19.98B |
| Enterprise Value | 18.04B |
Important Dates
The last earnings date was Friday, May 16, 2025.
| Earnings Date | May 16, 2025 |
| Ex-Dividend Date | Sep 17, 2024 |
Share Statistics
Windlas Biotech has 20.90 million shares outstanding. The number of shares has increased by 0.73% in one year.
| Current Share Class | 20.90M |
| Shares Outstanding | 20.90M |
| Shares Change (YoY) | +0.73% |
| Shares Change (QoQ) | +0.15% |
| Owned by Insiders (%) | 62.51% |
| Owned by Institutions (%) | 8.74% |
| Float | 7.83M |
Valuation Ratios
The trailing PE ratio is 32.66.
| PE Ratio | 32.66 |
| Forward PE | n/a |
| PS Ratio | 2.74 |
| PB Ratio | 4.24 |
| P/TBV Ratio | 4.29 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 29.24 |
| EV / Sales | 2.48 |
| EV / EBITDA | 22.26 |
| EV / EBIT | 26.78 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.23 |
| Debt / FCF | n/a |
| Interest Coverage | 20.22 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 9.23% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 6.31M |
| Profits Per Employee | 534,714 |
| Employee Count | 1,154 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +72.45% in the last 52 weeks. The beta is 0.35, so Windlas Biotech's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | +72.45% |
| 50-Day Moving Average | 973.80 |
| 200-Day Moving Average | 949.34 |
| Relative Strength Index (RSI) | 45.04 |
| Average Volume (20 Days) | 48,729 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Windlas Biotech had revenue of INR 7.28 billion and earned 617.06 million in profits. Earnings per share was 29.28.
| Revenue | 7.28B |
| Gross Profit | 2.70B |
| Operating Income | 673.78M |
| Pretax Income | 815.67M |
| Net Income | 617.06M |
| EBITDA | 793.58M |
| EBIT | 673.78M |
| Earnings Per Share (EPS) | 29.28 |
Balance Sheet
The company has 2.13 billion in cash and 189.53 million in debt, giving a net cash position of 1.94 billion or 92.85 per share.
| Cash & Cash Equivalents | 2.13B |
| Total Debt | 189.53M |
| Net Cash | 1.94B |
| Net Cash Per Share | 92.85 |
| Equity (Book Value) | 4.71B |
| Book Value Per Share | 225.40 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 37.12%, with operating and profit margins of 9.25% and 8.47%.
| Gross Margin | 37.12% |
| Operating Margin | 9.25% |
| Pretax Margin | 11.20% |
| Profit Margin | 8.47% |
| EBITDA Margin | 10.89% |
| EBIT Margin | 9.25% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 5.50, which amounts to a dividend yield of 0.58%.
| Dividend Per Share | 5.50 |
| Dividend Yield | 0.58% |
| Dividend Growth (YoY) | 37.50% |
| Years of Dividend Growth | 3 |
| Payout Ratio | n/a |
| Buyback Yield | -0.73% |
| Shareholder Yield | -0.14% |
| Earnings Yield | 3.09% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |